Salesforce Remains Down Over 12 Months: This Wall Street Firm Doubled Down On Its Belief That 70% Returns Await Investors

Salesforce (NYSE:CRM | CRM Price Prediction) currently trades at $233.28, while the Wall Street consensus 12-month price target sits at $281.89. That gap works out to roughly 20.8% of implied upside from here.

Salesforce is the default CRM platform for large enterprises. Its Agentforce agentic AI product is the central bull case. Wall Street is watching whether AI monetization can pull growth back into the mid-teens and justify a heavy multi-year investment cycle that includes the Informatica deal, pending Contentful and Fin closes, and a $25 billion accelerated share repurchase.

A Slow Bleed With a Sharp Week at the End

Salesforce shares are down 5.76% over the past year and 11.32% year to date, capped by an 8.58% drop in the past week. The stock has visibly lagged a software sector rewarding AI winners.

Q2 FY27 revenue of $11.35 billion grew 10.8% year over year, and FY27 guidance was raised to $46.1 billion to $46.4 billion. Low-teens growth, even with rising Agentforce contribution, has left investors questioning whether Salesforce is a legacy franchise being milked or a genuine AI winner. The reported $5.90 non-GAAP EPS looked strong, but a chunk came from $2.61 billion in strategic investment gains rather than the operating business.

A heavier debt load post-ASR, a $94 million restructuring charge in Q2, and Informatica integration overhang have weighed on the stock.

Why Needham Is Sticking With a $400 Call

Even after the drawdown, analysts have not blinked. The consensus target implies 20.8% upside, but Scott Berg at Needham & Company holds the Street-high $400 price target with a Buy rating. That target implies roughly 71.5% upside from current levels, well above the 40% threshold that usually signals an outlier bull case worth taking seriously.

Needham’s thesis rests on three pillars. First, Berg models Agentforce transitioning from early adoption to an enterprise ARR driver, capitalizing on consumption-based pricing. Agentforce ARR alone crossed $1.5 billion, up over 240% year over year, and combined Agentforce plus Data 360 ARR is nearly $3.9 billion. Second, the unified Data Cloud moat prevents point-solution churn as enterprises consolidate spend. Third, management’s reiterated $63 billion FY30 revenue target anchors the bull case.

Of the analysts tracked, 6 rate CRM Strong Buy, 34 Buy, 14 Hold, 0 Sell, and 2 Strong Sell. The FY27 EPS estimate has seen 45 upward revisions and zero downward revisions in the trailing 30 days. Analyst targets are one data point, not a promise, but the direction is up while the stock drifts sideways.

The pain extends across the CRM and enterprise software cohort, though details differ.

ServiceNow (NYSE:NOW) trades near $137, down 26.16% over the past year. The consensus target of $144.99 implies only 5.8% upside, with 10 Strong Buys, 35 Buys, 2 Holds, 1 Sell, and 1 Strong Sell. Wall Street is bullish but has already reset targets lower alongside the price.

Oracle (NYSE:ORCL) trades at $149.20, down a punishing 52.46% from a year ago as investors soured on massive AI-related capex. The consensus target of $237.97 points to 59.5% upside, with 8 Strong Buys, 28 Buys, 7 Holds, and 1 Sell. This is the largest consensus-level dislocation in the group.

HubSpot (NYSE:HUBS) sits at $217.88, off 57.54% over 12 months. The consensus target of $250.37 implies just 14.9% upside, and the rating mix skews cautious with 18 Holds against 15 Buy-equivalent ratings.

Salesforce holds the biggest Street-high call in the group at Needham’s $400. A modest 12-month drawdown paired with an outlier bull target makes CRM’s setup unique inside the cohort.

Salesforce trades at $233.28 against a consensus 12-month target of $281.89 from 56 covering analysts. That leaves 20.8% of implied upside on the average call, and roughly 71.5% on Needham’s Street-high.

The stock’s 11.32% year-to-date decline compares to a 13.42% gain for the S&P 500 proxy. That relative underperformance of roughly 25 percentage points explains the dislocation.

CRM trades at a forward P/E of 14, against management’s guided FY27 non-GAAP EPS of $16.67 to $16.71.

My Take on CRM at $233

The bull case for Salesforce holds if you believe Agentforce follows Needham’s trajectory and pushes total growth back toward the mid-teens by FY28, with consumption-based AI revenue layering on top of the existing subscription base. The 45 upward FY27 EPS revisions with zero downward revisions, the ARR ramp visible in Agentforce, and a forward P/E of 14 on rising numbers support the bull case. If those pieces line up, the path to Needham’s $400 is a re-rating story more than a heroic growth call.

The bear case dominates if you think Agentforce is an interesting product wrapped around a decelerating franchise. The $2.61 billion in strategic investment gains that inflated Q2 EPS, ballooning debt post-ASR, Informatica integration risk, and low-teens growth all argue the market is pricing CRM correctly as a mature software business rather than a re-accelerating AI platform.

The consensus 20.8% upside is defensible on the numbers, and Needham’s $400 is the option value if Agentforce inflects. The Street-high target is best treated as option value, not the base case.

Contact [email protected] for any questions or corrections.